Carl Icahn today acquired 30.6 million shares of Hologic Inc upon exercise of all of the call options according to SEC filing (below).
Carl Icahn may be deemed to beneficially own 34.2 million shares, representing approximately 12.51% of Hologic Inc outstanding shares.
SCHEDULE 13D
Item 1. Security and Issuer
The Schedule 13D filed with the Securities and Exchange Commission on November 21, 2013, as amended (the "Initial 13D"), by the Reporting Persons with respect to the shares of Common Stock, $0.01 par value ("Shares"), issued by Hologic, Inc. (the "Issuer") is hereby amended to furnish the additional information set forth herein. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Initial 13D.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Initial 13D is hereby amended and restated in its entirety as follows:
The Reporting Persons may be deemed to be the beneficial owner of, in the aggregate, 34,154,879 Shares. The aggregate purchase price of the Shares purchased by the Reporting Persons collectively was approximately $729.2 million (including commissions and premiums and exercise price for options to purchase Shares). The source of funding for these Shares was the general working capital of the respective purchasers. The Shares are held by the Reporting Persons in margin accounts together with other securities. Such margin accounts may from time to time have debit balances. Part of the purchase price of the Shares was obtained through margin borrowing.
Item 5. Interest in Securities of the Issuer
Item 5(a) of the Initial 13D is hereby amended and restated in its entirety as follows:
(a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 34,154,879 Shares, representing approximately 12.51% of the Issuer's outstanding Shares (based upon the 273,128,747 Shares stated to be outstanding as of September 28, 2013 by the Issuer in the Issuer's Form 10-K filed with the Securities and Exchange Commission on November 26, 2013).
Item 5(c) of the Initial 13D is hereby amended to add the following:
(c) On December 12, 2013, the Reporting Persons acquired 30,629,879 Shares upon exercise of all of the call options listed in the table set forth under Item 5(c) of the Initial 13D.
Item 6. Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
Item 6 of the Initial 13D is hereby amended to add the following:
On December 12, 2013, the Reporting Persons exercised all call options described in the Initial 13D and thereby acquired 30,629,879 Shares in the aggregate. On December 12, 2013, upon exercise of such call options, all put options described in the Initial 13D terminated in accordance with their terms.
Join the Conversation